SCHEMBL6582556

SCHEMBL6582556

NNC(=O)c1ccc2c(c1)CCC2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.62
RAB9A P51151 10/20 0.62
SMN1; SMN2 Q16637 7/20 0.62
ALDH1A1 P00352 4/20 0.62
MAPT P10636 4/20 0.62
TP53 P04637 3/20 0.62
LMNA P02545 2/20 0.58
GAA P10253 2/20 0.58
HPGD P15428 1/20 0.58
SMYD3 Q9H7B4 2/20 0.55
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
RXFP1 Q9HBX9 1/20 0.52
NFKB1 P19838 4/20 0.50
NFKB2 Q00653 4/20 0.50
RELA Q04206 4/20 0.50
PLAU P00749 1/20 0.50
HTT P42858 2/20 0.49
RECQL P46063 1/20 0.48
MPO P05164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17620525 0.92 ALDH1A1 (0.57) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL612135 0.83 ALDH1A1 (0.63) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL30147511 0.81 ALDH1A1 (0.61) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL368469 0.79 HDAC6 (0.59) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL24376508 0.79 NPC1 (0.57) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL24169997 0.79 ALDH1A1 (0.58) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL1719205 0.79 ALDH1A1 (0.68) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL29543577 0.79 ALDH1A1 (0.68) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL29649399 0.78 KMT2A (0.63) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL20812003 0.77 ALDH1A1 (0.56) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070708-B1 Triazole derivatives HOFFMANN LA ROCHE (CH) 2004-01-14 EP disclosed
US-6265426-B1 CENTRAL NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. 2001-07-24 US disclosed
EP-1070708-A1 Triazole and imidazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-01-24 EP disclosed